Workflow
Alzheimer's drug
icon
搜索文档
Mizuho's Jared Holz talks Novo Nordisk falling on Alzheimer's trial
Youtube· 2025-11-25 07:22
For more on the moves, Missouo healthcare strategist Jared Holes joins us here on set. Jared, great to have you with us. It felt like the bar was sort of low when it comes to Novo and the Alzheimer's data and yet the stock is moving this much lower.I mean, what what do you need to see at this point. What do I mean, is it a value trap here. I >> think you just need to see some resurrection of of its obesity drug in terms of revenue, right.Like it's hard to believe we're at four to five year lows with in the ...
Wall Street Opens Holiday Week Mixed as Rate Cut Hopes Fuel Tech Gains; Key Economic Data and Earnings Ahead
Stock Market News· 2025-11-24 23:07
The U.S. stock market opened Monday, November 24, 2025, with a mixed but generally positive tone, kicking off a holiday-shortened trading week. Investors are closely watching for fresh economic data and corporate earnings, all while growing increasingly confident about potential interest rate cuts by the Federal Reserve in the near future. The tech-heavy Nasdaq Composite and the benchmark S&P 500 saw gains at the open, while the Dow Jones Industrial Average experienced a slight dip.Market Indexes Performanc ...
Biogen Cuts Full-Year Earnings Guidance, Despite Third-Quarter Profit Rise
WSJ· 2025-10-30 19:40
公司业绩表现 - 公司第三季度利润增长 主要得益于阿尔茨海默病药物和罕见病治疗药物的强劲表现 [1] - 公司下调了全年调整后收益预期 [1]
INmune Bio shares tumble as Alzheimer's drug falls short in mid-stage trial
Proactiveinvestors NA· 2025-07-01 00:56
关于作者背景 - 作者Emily Jarvie曾担任澳大利亚社区媒体的政治记者 后专注于商业、法律及新兴 psychedelics 领域的报道 [1] - 其作品发表于澳大利亚、欧洲和北美多家媒体 包括The Examiner、The Advocate等 [1] 关于出版商定位 - 出版商Proactive提供快速、可操作的全球商业与金融新闻 内容由资深新闻团队独立制作 [2] - 团队覆盖伦敦、纽约、多伦多等全球主要金融中心 设有分支机构 [2] 内容覆盖领域 - 专注于中小市值公司 同时涵盖蓝筹股、大宗商品及广泛投资主题 [3] - 重点领域包括生物制药、矿业、电池金属、加密货币及电动汽车技术等 [3] 技术应用策略 - 采用自动化工具及生成式AI辅助工作流程 但所有内容均经过人工编辑与创作 [4][5] - 强调技术赋能的同时保持人类专业经验的核心地位 [4]